Physico-chemical characterisation, cytotoxic activity, and biocompatibility studies of tamoxifen-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification method

References

• Abbasalipourkabir R, Salehzadeh A, Abdullah R. Delivering tamoxifen within solid lipid nanoparticles. Pharmaceut Technol, 2011;35:74–80
   Google Scholar
• Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: The particle isolation hypothesis. Biochim Biophys Acta, 2000;1468:127–38
   PubMed Web of Science ®Google Scholar
• Altankov G, Richau K, Groth T. The role of surface zeta potential and substratum chemistry for regulation of dermal fibroblasts interaction. Materialwissenschaft und Werkstofftechnik, 2003;34:1120–8
   Web of Science ®Google Scholar
• Bae KH, Lee JY, Lee SH, Park TG, Nam YS. Cancer therapy: Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging (Adv. Healthcare Mater. 4/2013). Adv Healthcare Mater, 2013a;2:513
   Web of Science ®Google Scholar
• Bae KH, Lee JY, Lee SH, Park TG, Nam YS. Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging. Adv Healthcare Mater, 2013b;2:576–84
   Web of Science ®Google Scholar
• Baydoun L, Muller-Goymann CC. Influence of n-octenylsuccinate starch on in vitro permeation of sodium diclofenac across excised porcine cornea in comparison to Voltaren ophtha. Eur J Pharm Biopharm, 2003;56:73–9
   PubMed Web of Science ®Google Scholar
• Bildstein L, Hillaireau H, Desmaele D, Lepetre-Mouelhi S, Dubernet C, Couvreur P. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. Int J Pharm, 2009;381:140–5
   PubMed Web of Science ®Google Scholar
• Brigger I, Chaminade P, Marsaud V, Appel M, Besnard M, Gurny R, Renoir M, Couvreur P. Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. Int J Pharm, 2001;214:37–42
   PubMed Web of Science ®Google Scholar
• Brus C, Kleemann E, Aigner A, Czubayko F, Kissel T. Stabilization of oligonucleotide-polyethylenimine complexes by freeze-drying: Physicochemical and biological characterization. J Control Release, 2004;95:119–31
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm, 2007;336:367–75
   PubMed Web of Science ®Google Scholar
• Cavalli R, Caputo O, Carlotti E, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm, 1997;148:47–54
   Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(∈-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm, 2002;249:127–38
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Cellular uptake and concentrations of tamoxifen upon administration in poly (ϵ-caprolactone) nanoparticles. Aaps Pharmsci, 2003;5:28–34
   Google Scholar
• Del Pozo-Rodriguez A, Solinis MA, Gascon AR, Pedraz JL. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm, 2009;71:181–9
   PubMed Web of Science ®Google Scholar
• Dong Y, Ng WK, Shen S, Kim S, Tan RBH. Solid lipid nanoparticles: Continuous and potential large-scale nanoprecipitation production in static mixers. Colloids Surf B, 2012;94:68–72
   PubMed Web of Science ®Google Scholar
• Feng F, Zheng D, Zhang D, Duan C, Wang Y, Jia L, Wang F, Liu Y, Gao Q, Zhang Q. Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate. J Microencapsul, 2011;28:280–5
   PubMed Web of Science ®Google Scholar
• Garg A, Singh S. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids Surf B Biointerfaces, 2011;87:280–8
   PubMed Web of Science ®Google Scholar
• Heiati H, Tawashi R, Phillips NC. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J Microencapsulation, 1998;15:173–84
   PubMed Web of Science ®Google Scholar
• Heydenreich AV, Westmeier R, Pedersen N, Poulsen HS, Kristensen HG. Preparation and purification of cationic solid lipid nanospheres -- Effects on particle size, physical stability and cell toxicity. Int J Pharm, 2003;254:83–7
   PubMed Web of Science ®Google Scholar
• Huang ZR, Hua SC, Yang YL, Fang JY. Development and evaluation of lipid nanoparticles for camptothecin delivery: A comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin, 2008;29:1094–102
   PubMed Web of Science ®Google Scholar
• Izutsu K, Kojima S. Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying. J Pharm Pharmacol, 2002;54:1033–9
   PubMed Web of Science ®Google Scholar
• Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Rel, 2010;148:359–67
   PubMed Web of Science ®Google Scholar
• Kang KW, Chun M-K, Kim O, Subedi RK, Ahn S-G, Yoon J-H, Choi H-K. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomedicine (Philadelphia, PA, U.S.), 2010a;6:210–13
   Google Scholar
• Kang KW, Chun MK, Kim O, Subedi RK, Ahn SG, Yoon JH, Choi HK. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomedicine, 2010b;6:210–13
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25–35
   Web of Science ®Google Scholar
• Kramer R, Brown P. Should tamoxifen be used in breast cancer prevention? Drug Saf, 2004;27:979–89
   PubMed Web of Science ®Google Scholar
• Lee M-K, Lim S-J, Kim C-K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials, 2007;28:2137–46
   PubMed Web of Science ®Google Scholar
• Li Z, Yu L, Zheng L, Geng F. Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method. J Therm Anal Calorim, 2010;99:689–93
   Web of Science ®Google Scholar
• Ma Z-H, Yu D-G, Branford-White CJ, Nie H-L, Fan Z-X, Zhu L-M. Microencapsulation of tamoxifen: Application to cotton fabric. Colloids Surf, B, 2009;69:85–90
   PubMed Web of Science ®Google Scholar
• Macgregor JI, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev, 1998;50:151–96
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 1986;46:6387–92
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Delivery Rev, 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Minelli R, Occhipinti S, Gigliotti CL, Barrera G, Gasco P, Conti L, Chiocchetti A, Zara GP, Fantozzi R, Giovarelli M, et al. Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. Br J Pharmacol, 2013;170:233–44
   PubMed Web of Science ®Google Scholar
• Mosallaei N, Jaafari MR, Hanafi-Bojd MY, Golmohammadzadeh S, Malaekeh-Nikouei B. Docetaxel-loaded solid lipid nanoparticles: Preparation, characterization, in vitro, and in vivo evaluations. J Pharm Sci, 2013;102:1994–2004
   PubMed Web of Science ®Google Scholar
• Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, et al. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol, 2003;21:2101–9
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – A review of the state of the art. Eur J Pharm Biopharm, 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Nicolson GL. Lipid replacement therapy: A nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function. Cancer Metastasis Rev, 2010;29(3):543–52
   PubMed Web of Science ®Google Scholar
• Nicolson GL, Conklin KA. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis, 2008;25:161–9
   PubMed Web of Science ®Google Scholar
• Oerlemans C, Bult W, Bos M, Storm G, Nijsen JFW, Hennink WE. Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm Res, 2010;27:2569–89
   Google Scholar
• Panis C, Herrera ACSA, Victorino VJ, Campos FC, Freitas LF, Rossi T, Colado Simao AN, Cecchini AL, Cecchini R. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat, 2012;133:89–97
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharmaceut, 2009;366:170–84
   PubMed Web of Science ®Google Scholar
• Park JH, Lee S, Kim J-H, Park K, Kim K, Kwon IC. Polymeric nanomedicine for cancer therapy. Prog Polym Sci, 2008;33:113–37
   Web of Science ®Google Scholar
• Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;59:411–18
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan MA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm, 2010;76:127–37
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Singal P, Wadhwa S, Katare OP. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B, 2013;105:67–74
   PubMed Web of Science ®Google Scholar
• Reddy LH. Drug delivery to tumors: Recent strategies. J Pharm Pharmacol, 2005;57:1231–42
   PubMed Web of Science ®Google Scholar
• Reddy LH, Vivek K, Bakshi N, Murthy RSR. Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharmaceut Dev Technol, 2006;11:167–77
   PubMed Web of Science ®Google Scholar
• Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm, 2005;61:77–86
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm, 1997;157:171–9
   PubMed Web of Science ®Google Scholar
• Shahgaldian P, Gualbert J, Aissa K, Coleman AW. A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur J Pharm Biopharm, 2003;55:181–4
   PubMed Web of Science ®Google Scholar
• Shin S-C, Choi J-S, Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int J Pharmaceut, 2006;313:144–9
   PubMed Web of Science ®Google Scholar
• Silva AC, Kumar A, Wild W, Ferreira D, Santos D, Forbes B. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Int J Pharm, 2012;436:798–805
   PubMed Web of Science ®Google Scholar
• Singh AP, Saraf SK, Saraf SA. SLN approach for nose-to-brain delivery of alprazolam. Drug Deliv Transl Res, 2012;2:498–507
   PubMed Web of Science ®Google Scholar
• Sporn MB, Lippman SM. 2003. Agents for chemoprevention and their mechanism of action. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei 3rd E, eds. Holland-Frei cancer medicine, 6th edn. Hamilton (ON): BC Decker . Available at: http://www.ncbi.nlm.nih.gov/books/NBK12522/
   Google Scholar
• Stapleton S, Allen C, Pintilie M, Jaffray D A. Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes. J. Control Release, 2013;172:351–7
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Kojima H, Toyoda T, Yamamoto H, Hino T, Kawashima Y. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats. Eur J Pharm Biopharm, 1999;48:123–9
   PubMed Web of Science ®Google Scholar
• Tranum K, Roderick S. 2013. Solid lipid nanoparticles: Tuneable anti-cancer gene/drug delivery systems . Rijeka, Croatia: Intech
   Google Scholar
• Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, et al. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol, 2009;27:3235–58
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Peng H, Li Y, Xiong J, Xu Z. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C, 2013;33:4802–8
   PubMed Web of Science ®Google Scholar
• Welter M, Rieger H. Interstitial fluid flow and drug delivery in vascularized tumors: A computational model. PLoS One, 2013;8:e70395
   Web of Science ®Google Scholar
• Wesolowski R, Budd GT. Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders. Curr Oncol Rep, 2009;11:37–44
   PubMed Web of Science ®Google Scholar
• Wintner LM, Giesinger JM, Zabernigg A, Sztankay M, Meraner V, Pall G, Hilbe W, Holzner B. Quality of life during chemotherapy in lung cancer patients: Results across different treatment lines. Br J Cancer, 2013;109:2301–8
   PubMed Web of Science ®Google Scholar
• Wunder SL, Merajver SD. Raman spectroscopic study of the conformational order in hexadecane solutions. J Chem Phys, 1981;74:5341–6
   Web of Science ®Google Scholar
• Zhang J, Fan Y, Smith E. Experimental design for the optimization of lipid nanoparticles. J Pharm Sci, 2009;98:1813–19
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang M, Portney NG, Cui D, Budak G, Ozbay E, Ozkan M, Ozkan CS. Zeta potential: A surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdev, 2008;10:321–8
   PubMed Web of Science ®Google Scholar
• Zhong S, Li W, Chen Z, Xu J, Zhao J. miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene, 2013;531:8–14
   PubMed Web of Science ®Google Scholar
• Zhuang YG, Xu B, Huang F, Wu JJ, Chen S. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model. Pharmazie, 2012;67:925–9
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Souto EB, Muller RH. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR. Pharmazie, 2005;60:508–13
   PubMed Web of Science ®Google Scholar